Intu Diagnostics logo

Intu Diagnostics

Develops lab-free cervical cancer diagnostics designed to work anywhere, without electricity or access to a laboratory.

Deep Tech
Lab-free Diagnostics
Total Raised
$4M
Last Valuation
$20M
Headquarters
San Francisco, CA

Overview

Intu Diagnostics is a German spinout developing a cervical cancer test intended for use outside traditional laboratories. Its platform targets lab-free testing that can move closer to patients, including settings without electricity or clinical infrastructure. The company’s stated differentiator is accessibility: a test that works anywhere without a lab, supporting decentralized screening and earlier detection. Intu Diagnostics has raised about $4 million across two rounds, including a €1.1 million bridge round and more than €3 million in undisclosed funding announced in June 2026.

Funding History

2 rounds · Jun 2026 – Jun 2026
$4M
Total Raised
2
Valuation: $20M
Cumulative: $4M

German spinout raises over €3M to tackle cervical cancer with a test that works anywhere without electricity or a lab

Investors not disclosed
Source
1
Valuation: $7M
Cumulative: $1M

Lab-free testing moves closer to home as Germany’s Intu Diagnostics raises €1.1 million

Investors not disclosed
Source

Frequently Asked Questions

How much has Intu Diagnostics raised in total?
Intu Diagnostics has raised a total of $4M across 2 funding rounds.
Who are Intu Diagnostics's investors?
Intu Diagnostics's investors include Undisclosed.
What does Intu Diagnostics do?
Intu Diagnostics is a German spinout developing a cervical cancer test intended for use outside traditional laboratories. Its platform targets lab-free testing that can move closer to patients, including settings without electricity or clinical infrastructure. The company’s stated differentiator is accessibility: a test that works anywhere without a lab, supporting decentralized screening and earlier detection. Intu Diagnostics has raised about $4 million across two rounds, including a €1.1 million bridge round and more than €3 million in undisclosed funding announced in June 2026.
Where is Intu Diagnostics headquartered?
Intu Diagnostics is headquartered in San Francisco, CA.